Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
For the nine months, net loss was USD 1.91 million compared to USD 1.75 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00075 USD | -10.71% | -20.00% | -93.33% |
1st Jan change | Capi. | |
---|---|---|
-93.33% | 137K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |